The contemporary (over)treatment of rectal cancer: The Goldilocks effect

Diseases of the Colon and Rectum

Volumn 57, Issue 3, 2014, Pages 403-406

  Fleming, F J ^a   Monson, J R T ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER STAGING; CHEMORADIOTHERAPY; CLINICAL DECISION MAKING; CLINICAL PROTOCOL; HUMAN; MORBIDITY; NOTE; OVERALL SURVIVAL; PREOPERATIVE RADIOTHERAPY; RECTUM CANCER; RECTUM SURGERY; ARTICLE; CLINICAL PRACTICE; COLORECTAL SURGERY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTUM TUMOR; STATISTICS; SURVIVAL RATE; TUMOR INVASION;

COLORECTAL SURGERY; COMBINED MODALITY THERAPY; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PHYSICIAN'S PRACTICE PATTERNS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECTAL NEOPLASMS; SURVIVAL RATE;

EID: 84897576010     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0000000000000042     Document Type: Note

References (20)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11-30.
2. van Gijn W, Krijnen P, Lemmens VE, den Dulk M, Putter H, van de Velde CJ. Quality assurance in rectal cancer treatment in the Netherlands: a catch up compared to colon cancer treatment. Eur J Surg Oncol. 2010;36:340-344.
3. Wibe A, Eriksen MT, Syse A, Tretli S, Myrvold HE, Søreide O; Norwegian Rectal Cancer Group. Effect of hospital caseload on long-term outcome after standardization of rectal cancer surgery at a national level. Br J Surg. 2005;92:217-224.
4. National Comprehensive Cancer Network. NCNN Guidelines on rectal cancer. http://www.nccn.org/professionals/physician-gls/f-guidelines.asp#rectal. Accessed November 21, 2013.
5. Glimelius B, Påhlman L, Cervantes A; ESMO Guidelines Working Group. Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(suppl 5):v82-v86.
6. Gunderson LL, Sargent DJ, Tepper JE, et al. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol. 2004;22:1785-1796.
7. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al.; Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638-646.
8. van Gijn W, Marijnen CA, Nagtegaal ID, et al.; Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011;12:575-582.
9. Aly EH. Time for a renewed strategy in the management of rectal cancer: critical reflection on the surgical management of rectal cancer over 100 years. Dis Colon Rectum. 2014:57:399-402.
10. Peeters KC, van de Velde CJ, Leer JW, et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients-a Dutch colorectal cancer group study. J Clin Oncol. 2005;23:6199-6206.
11. Birgisson H, Påhlman L, Gunnarsson U, Glimelius B. Late gastrointestinal disorders after rectal cancer surgery with and without preoperative radiation therapy. Br J Surg. 2008;95:206-213.
12. Hoerske C, Weber K, Goehl J, Hohenberger W, Merkel S. L ong-term outcomes and quality of life after rectal carcinoma surgery. Br J Surg. 2010;97:1295-1303.
13. Sauer R, Becker H, Hohenberger W, et al.; German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731-1740.
14. Garcia-Aguilar J, Pollack J, Lee SH, et al. Accuracy of endorectal ultrasonography in preoperative staging of rectal tumors. Dis Colon Rectum. 2002;45:10-15.
15. Group MS. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ. 2006;333:779.
16. Taylor FG, Quirke P, Heald RJ, et al.; MERCURY study group. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and II rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg. 2011;253:711-719.
17. Strassburg J, Ruppert R, Ptok H, et al. MRI-based indications for neoadjuvant radiochemotherapy in rectal carcinoma: interim results of a prospective multicenter observational study. Ann Surg Oncol. 2011;18:2790-2799.
18. Nagtegaal ID, van de Velde CJ, van der Worp E, Kapiteijn E, Quirke P, van Krieken JH; Cooperative Clinical Investigators of the Dutch Colorectal Cancer Group. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol. 2002;20:1729-1734.
19. Quirke P, Steele R, Monson J, et al.; MRC CR07/NCIC-CTG CO16 Trial Investigators; NCRI Colorectal Cancer Study Group. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet. 2009;373:821-828.
20. Maslekar S, Sharma A, Macdonald A, Gunn J, Monson JR, Hartley JE. Mesorectal grades predict recurrences after curative resection for rectal cancer. Dis Colon Rectum. 2007;50:168-175.